WO2007011156A1 - Novel microorganism catalyzing regioselective hydroxylation of 6 cyclic compound containing nitrogen and method for producing hydroxylated 6 cyclic compound containing nitrogen using the same - Google Patents
Novel microorganism catalyzing regioselective hydroxylation of 6 cyclic compound containing nitrogen and method for producing hydroxylated 6 cyclic compound containing nitrogen using the same Download PDFInfo
- Publication number
- WO2007011156A1 WO2007011156A1 PCT/KR2006/002823 KR2006002823W WO2007011156A1 WO 2007011156 A1 WO2007011156 A1 WO 2007011156A1 KR 2006002823 W KR2006002823 W KR 2006002823W WO 2007011156 A1 WO2007011156 A1 WO 2007011156A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- group
- microorganism
- formula
- compound represented
- acid
- Prior art date
Links
- 244000005700 microbiome Species 0.000 title claims abstract description 75
- 238000005805 hydroxylation reaction Methods 0.000 title claims abstract description 38
- 230000033444 hydroxylation Effects 0.000 title claims abstract description 37
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 12
- 229910052757 nitrogen Inorganic materials 0.000 title claims description 17
- 150000001923 cyclic compounds Chemical class 0.000 title abstract description 20
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 title description 20
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims abstract description 68
- 239000011664 nicotinic acid Substances 0.000 claims abstract description 34
- 229960003512 nicotinic acid Drugs 0.000 claims abstract description 34
- 235000001968 nicotinic acid Nutrition 0.000 claims abstract description 34
- 241000588813 Alcaligenes faecalis Species 0.000 claims abstract description 32
- 229940005347 alcaligenes faecalis Drugs 0.000 claims abstract description 32
- 150000001875 compounds Chemical class 0.000 claims abstract description 32
- 241000588986 Alcaligenes Species 0.000 claims abstract description 24
- NIPZZXUFJPQHNH-UHFFFAOYSA-N pyrazine-2-carboxylic acid Chemical compound OC(=O)C1=CN=CC=N1 NIPZZXUFJPQHNH-UHFFFAOYSA-N 0.000 claims abstract description 20
- SIOXPEMLGUPBBT-UHFFFAOYSA-N picolinic acid Chemical compound OC(=O)C1=CC=CC=N1 SIOXPEMLGUPBBT-UHFFFAOYSA-N 0.000 claims abstract description 18
- 229940081066 picolinic acid Drugs 0.000 claims abstract description 9
- 238000000034 method Methods 0.000 claims description 30
- 108090000790 Enzymes Proteins 0.000 claims description 20
- 102000004190 Enzymes Human genes 0.000 claims description 20
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 15
- 229910052799 carbon Inorganic materials 0.000 claims description 11
- -1 carboxylvinyl group Chemical group 0.000 claims description 11
- 239000000126 substance Substances 0.000 claims description 10
- 108020004465 16S ribosomal RNA Proteins 0.000 claims description 7
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 7
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims description 7
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims description 7
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 7
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 claims description 7
- 229910052739 hydrogen Inorganic materials 0.000 claims description 7
- 239000001257 hydrogen Substances 0.000 claims description 7
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 7
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims description 7
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 7
- 125000003544 oxime group Chemical group 0.000 claims description 7
- 238000012258 culturing Methods 0.000 claims description 3
- 125000004432 carbon atom Chemical group C* 0.000 claims 4
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 abstract description 15
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 abstract description 2
- 229960002715 nicotine Drugs 0.000 abstract description 2
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 abstract description 2
- 150000003216 pyrazines Chemical class 0.000 abstract description 2
- 230000002194 synthesizing effect Effects 0.000 abstract description 2
- 238000006243 chemical reaction Methods 0.000 description 26
- BLHCMGRVFXRYRN-UHFFFAOYSA-N 6-hydroxynicotinic acid Chemical compound OC(=O)C1=CC=C(O)N=C1 BLHCMGRVFXRYRN-UHFFFAOYSA-N 0.000 description 23
- 239000002609 medium Substances 0.000 description 18
- 239000000047 product Substances 0.000 description 17
- 238000004949 mass spectrometry Methods 0.000 description 15
- 238000001228 spectrum Methods 0.000 description 14
- 238000004128 high performance liquid chromatography Methods 0.000 description 12
- 230000000813 microbial effect Effects 0.000 description 11
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 11
- 238000004458 analytical method Methods 0.000 description 9
- 239000000243 solution Substances 0.000 description 7
- WSGYTJNNHPZFKR-UHFFFAOYSA-N 3-hydroxypropanenitrile Chemical compound OCCC#N WSGYTJNNHPZFKR-UHFFFAOYSA-N 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 239000007795 chemical reaction product Substances 0.000 description 4
- 238000006731 degradation reaction Methods 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 238000005160 1H NMR spectroscopy Methods 0.000 description 3
- FJZRUSFQHBBTCC-UHFFFAOYSA-N 2-oxo-1h-pyrazine-3-carboxylic acid Chemical compound OC(=O)C1=NC=CNC1=O FJZRUSFQHBBTCC-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 150000001721 carbon Chemical group 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 210000000349 chromosome Anatomy 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- GZPHSAQLYPIAIN-UHFFFAOYSA-N 3-pyridinecarbonitrile Chemical compound N#CC1=CC=CN=C1 GZPHSAQLYPIAIN-UHFFFAOYSA-N 0.000 description 2
- CGQFCIHUUCMACC-UHFFFAOYSA-N 6-oxo-1h-pyrazine-3-carboxylic acid Chemical compound OC(=O)C1=CNC(=O)C=N1 CGQFCIHUUCMACC-UHFFFAOYSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- 108010023063 Bacto-peptone Proteins 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 239000005906 Imidacloprid Substances 0.000 description 2
- 238000007065 Kolbe-Schmitt synthesis reaction Methods 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 2
- 229940056881 imidacloprid Drugs 0.000 description 2
- YWTYJOPNNQFBPC-UHFFFAOYSA-N imidacloprid Chemical compound [O-][N+](=O)\N=C1/NCCN1CC1=CC=C(Cl)N=C1 YWTYJOPNNQFBPC-UHFFFAOYSA-N 0.000 description 2
- 239000002917 insecticide Substances 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 238000002514 liquid chromatography mass spectrum Methods 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 239000000376 reactant Substances 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- XUFGVLRUKBIUGH-UHFFFAOYSA-N 3-hydroxy-2h-pyridine-3-carboxylic acid Chemical compound OC(=O)C1(O)CN=CC=C1 XUFGVLRUKBIUGH-UHFFFAOYSA-N 0.000 description 1
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- VRCWSYYXUCKEED-UHFFFAOYSA-N 6-Hydroxypicolinic acid Chemical compound OC(=O)C1=CC=CC(=O)N1 VRCWSYYXUCKEED-UHFFFAOYSA-N 0.000 description 1
- 241001673062 Achromobacter xylosoxidans Species 0.000 description 1
- 241000589158 Agrobacterium Species 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 1
- 241000607720 Serratia Species 0.000 description 1
- 241000607715 Serratia marcescens Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000011942 biocatalyst Substances 0.000 description 1
- VEMKTZHHVJILDY-UXHICEINSA-N bioresmethrin Chemical compound CC1(C)[C@H](C=C(C)C)[C@H]1C(=O)OCC1=COC(CC=2C=CC=CC=2)=C1 VEMKTZHHVJILDY-UXHICEINSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 150000004657 carbamic acid derivatives Chemical class 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000006114 decarboxylation reaction Methods 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 239000006151 minimal media Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 239000008057 potassium phosphate buffer Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/10—Nitrogen as only ring hetero atom
- C12P17/12—Nitrogen as only ring hetero atom containing a six-membered hetero ring
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/02—Oxygen as only ring hetero atoms
- C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/16—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
- C12P17/165—Heterorings having nitrogen atoms as the only ring heteroatoms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/05—Alcaligenes
Definitions
- the present invention relates to a novel microorganism of the genus Alcaligenes, which catalyzes the regioselective hydroxylation of nitrogen-containing six- memhered cyclic compounds, including nicotinic acid, pyrazine carboxylic acid and picolinic acid, as well as a method for producing a nitrogen-containing hydroxylated six-membered cyclic compound using said microorganism.
- Imidacloprid and related compounds which are used as insecticides, have a significant difference from existing insecticides such as organophorphorus compounds, carbamates and pyrethroids with respect to the structure and function thereof.
- Substances which are commonly present in nicotinoid compounds, including Imidacloprid include 6-hydroxynicotinic acid.
- the Kolbe-Schmitt reaction is used, but has shortcomings in that it has a yield of only about 45% and requires a high-pressure (130 arm) carbon dioxide atmosphere and a high-temperature (250 ° C) reaction condition. For this reason, there has been a need to develop a process of producing 6-hydroxynicotinic acid with a higher yield in a milder condition compared to the Kolbe-Schmitt reaction.
- Processes of producing 6-hydroxynicotinic acid from nicotinic acid using a microbial biocatalyst have been reported, but these processes mainly employed a method of accumulating 6-hydroxynicotinic acid in the metabolic process of nicotinic acid degradation products which are used as a nitrogen source and carbon source for microorganisms.
- microorganisms accumulating 6- hydroxynicotinic acid, the first product of the nicotinic acid degradation process were isolated mainly by an enrichment process.
- Examples of the isolated microorganisms include Achromobacter xylosoxidans LKl) (Kulla, H., Chimia, 45:81, 1991), Pseudomomas fluorescens TN5) (Nagasawa et ah, Biosci. Biotechnol. Biochem., 58:665, 1994) and Serratia marcescens IFO 12648) (Hurh et al, J. Ferment. Technol, 77:382, 1994).
- JP Publication No.1998-262691 discloses a microorganism of the genus Serratia, which can produce 3-hydroxynicotinic acid by catalyzing a hydroxylation reaction involving the decarboxylation of the carboxyl group of nicotinic acid.
- JP Registration No. 3220210 discloses a microorganism of the genus Agrobacterium, which can convert 3-cyanopyridine into 6- hydroxynicotinic acid.
- the present inventors have made extensive efforts to isolate a microorganism catalyzing the regioselective hydroxylation of nitrogen-containing six-membered cyclic compounds.
- the present inventors have isolated a novel microorganism Alcaligenes faecalis LGNA2 capable of effectively producing 6- hydroxynicotinic acid by examining the conversion of nicotinic acid in microorganisms isolated during the degradation process of nitrile compounds (e.g., 3-hydroxypropionitrile, 3-cyanopyridine, etc.), and found that this microorganism can convert nicotinic acid into 6-hydroxynicotinic acid, thereby completing the present invention.
- nitrile compounds e.g., 3-hydroxypropionitrile, 3-cyanopyridine, etc.
- a main object of the present invention is to provide a novel microorganism which not only catalyzes the regioselective reaction of nicotinic acid to produce 6- hydroxylicotinic acid with high efficiency, but also catalyzes the regioselective hydroxylation of nitrogen-containing six-membered cyclic compounds.
- Another object of the present invention is to provide a method for producing a nitrogen-containing hydroxylated six-membered cyclic compound using said microorganism.
- the present invention provides a microorganism of the genus Alcaligenes, which catalyzes the regioselective hydroxylation of a compound represented by Formula 1 : [Formula 1]
- R is a carbon atom or a nitrogen atom
- Rl and R2 are each independently hydrogen, a carboxyl group, a carbamoyl group, a cyano group, a formyl group, a C 1 -Cs hydroxyalkyl group, a C 2 -C 6 alkoxycarbonyl group, a carboxylvinyl group, a carboxymethyl group or an oxime group, with the proviso that one of Rl and R2 must be a carboxyl group.
- the present invention provides a method for producing a compound represented by Formula 2, the method comprising carrying out the selective hydroxylation of a compound represented by Formula 1 using said microorganism of the genus Alcaligenes: [Formula 2]
- R is a carbon atom or a nitrogen atom
- Rl and R2 are each independently hydrogen, a carboxyl group, a carbamoyl group, a cyano group, a formyl group, a C 1 -C 5 hydroxyalkyl group, a C 2 -C 6 alkoxycarbonyl group, a carboxylvinyl group, a carboxymethyl group or an oxime group, with the proviso that one of Rl and R2 must be a carboxyl group.
- the present invention provides a method for preparing an enzyme catalyzing the regioselective hydroxylation of the compound represented by Formula 1, the method comprising culturing said microorganism of the genus Alcaligenes; and recovering the enzyme catalyzing the regioselective hydroxylation of the compound represented by Formula 1 from the cultured microorganism. Also, the present invention provides a method for producing the compound of Formula 2, the method comprising carrying out the selective hydroxylation of the compound of Formula 1 using the enzyme prepared by said method, or a crushed substance or fraction of the microorganism containing said enzyme.
- said microorganism of the genus Alcaligenes is preferably Alcaligenes faecalis, and has 16S rRNA having a homology of more than 99% to a base sequence of SEQ ID NO: 1. More preferably, said microorganism of the genus Alcaligenes is Alcaligenes faecalis LGNA2 (KCTC 10779BP).
- the compound represented by Formula 1 is preferably selected from the group consisting of nicotinic acid, pyrazine carboxylic acid and picolinic acid.
- FIG. 1 shows identification results obtained by microbial fatty acid analysis (MIDI) of Alcaligenes faecalis LGNA2, a novel microorganism isolated according to the present invention.
- MIDI microbial fatty acid analysis
- FIG. 2A and 2B show HPLC chromatograms of a product at 0 hour and 63 hours after performing the conversion of nicotinic acid using Alcaligenes faecalis LGNA2, and
- FIG 2C shows HPLC chromatogram of standard 6-hydroxynicotinic acid.
- FIG. 3 A shows the 1 H-NMR spectrum of standard 6-hydroxynicotinic acid
- FIG. 3B shows the 1 H-NMR spectrum of a product resulting from the conversion of nicotinic acid, caused by Alcaligenes faecalis LGNA2.
- FIG. 4A shows the mass spectrometry (MS) spectrum of standard 6- hydroxynicotinic acid
- FIG. 4B shows the MS spectrum of a product resulting from the conversion of nicotinic acid, caused by Alcaligenes faecalis LGNA2.
- FIG. 5A, 5B and 5C show an HPLC chromatogram of a product resulting from the conversion of pyrazine carboxylic acid, caused by Alcaligenes faecalis LGNA2 at 0 hour, 4 hours and 20 hours after the conversion reaction, respectively.
- FIG. 6 shows 1 H-NMR spectra illustrating the conversion of pyrazine carboxylic acid, caused by Alcaligenes faecalis LGNA2.
- FIG. 6A shows the 1 H-NMR spectrum of reactant pyrazine carboxylic acid
- FIG. 6B shows the H-NMR spectrum of a reaction product.
- FIG. 7 illustrates the mass spectrometry (MS) spectra of a product resulting from the conversion of pyrazine carboxylic acid, caused by Alcaligenes faecalis LGNA2, and shows an LC-MS spectrum, the MS spectrum of peak 1 and the MS spectrum of peak 2, starting with the top of the figure, respectively.
- MS mass spectrometry
- Alcaligenes faecalis LGNA2 a novel microorganism of the genus Alcaligenes, was obtained using a method of isolating the microorganism during the degradation process of nitrile compounds, instead of using a method of isolating a microorganism producing 6-hydroxynicotinic acid through the degradation of nicotinic acid, and it was found that the obtained microorganism converts nicotinic acid into 6-hydroxynicotinic acid with high efficiency.
- the present invention in one aspect, relates to a microorganism of the genus Alcaligenes which catalyzes the regioselective hydroxylation of a compound represented by Formula 1 and a method for producing a compound represented by Formula 2, the method comprising carrying out the selective hydroxylation of a compound represented by Formula 1 using said microorganism of the genus Alcaligenes: [Formula 1]
- R is a carbon atom or a nitrogen atom
- Rl and R2 are each independently hydrogen, a carboxyl group, a carbamoyl group, a cyano group, a formyl group, a C 1 -Cs hydroxyalkyl group, a C 2 -C 6 alkoxycarbonyl group, a carboxylvinyl group, a carboxymethyl group or an oxime group, with the proviso that one of Rl and R2 must be a carboxyl group.
- a hydroxide represented by Formula 2 could be produced directly by catalyzing the regioselective hydroxylation of a nitrogen-containing 6- membered cyclic compound represented by Formula 1.
- the microorganism according to the present invention not only can catalyze the regioselective hydroxylation of nicotinic acid to produce 6- hydroxynicotinic acid, but also can convert 2-pyrazinecarboxylic acid and picolinic acid into 5-hydroxy pyrazine-2-carboxylic acid and 6-hydroxypicolinic acid, respectively.
- an enzyme catalyzing the regioselective hydroxylation of the compound represented by Formula 1 recovered from the microorganism of the genus Alcaligenes can be used.
- the present invention in another aspect, relates to a method for preparing an enzyme catalyzing the regioselective hydroxylation of the compound represented by Formula 1 , the method comprising culturing said microorganism of the genus
- Alcaligenes and recovering the enzyme catalyzing the regioselective hydroxylation of the compound represented by Formula 1 from the cultured microorganism, and a method for producing the compound of Formula 2, the method comprising carrying out the selective hydroxylation of the compound of Formula 1 using the enzyme prepared by said method or a crushed substance or fraction of the microorganism containing said enzyme.
- the enzyme catalyzing the regioselective hydroxylation of the compound represented by Formula 1 can be retrieved from the cultured microorganism of the genus Alcaligenes using the conventional method.
- a method for recovering the enzyme comprising the steps of: collecting the cells from the culture broth by centrifugation, etc; crushing the collected cells; and applying to chromatography, etc.
- crushed substance refers to a substance which is obtained by crushing cultured microorganism with, for example, a grinder, and contains the inventive enzyme capable of catalyzing the hydroxylation of nitrogen- containing six-membered cyclic compounds.
- fraction refers to a substance which is obtained by partially purifying an enzyme from said crushed substance and contains the inventive enzyme capable of catalyzing the hydroxylation of nitrogen-containing six-membered cyclic compounds.
- Example 1 Isolation of microorganism converting nicotinic acid into 6- hydroxynicotinic acid
- a microorganism that degrades 3-hydroxypropionitrile and uses the degraded substance as a single carbon source was isolated from a soil source.
- GHPN medium and HPN medium were prepared and used.
- the GHPN medium was prepared by adding 5 g/L of glucose and 20 g/L of 3-hydroxypropionitrile as a nitrogen source to a minimal medium containing the components shown in Tables 1 and 2.
- the HPN medium a medium of using 3-hydroxypropionitrile as a single carbon source and nitrogen source, was prepared by adding 20 g/L of 3-hydroxypropionitrile as a nitrogen source to a minimal medium containing the components shown in Tables 1 and 2.
- solid media HPN agar prepared by adding glucose (10 g/L) as a carbon source and 3-hydroxypropionitrile as a nitrogen source (5 g/L) to LB medium plate and minimal media were used.
- a soil microbial source was added into 5 ml of liquid medium (GHPN medium and HPN medium) and subjected to enrichment culture in a shaking incubator under conditions of 200 rpm and 30 ° C for 3 days. Then, 1 ml of the culture broth as a microbial source was seeded again into the same liquid medium as described above, and then subjected to enrichment culture in the same conditions as described above. The culture process was repeated three times, and then the culture broth was plated onto an HPN agar solid medium, and cultured to produce a single colony. Microorganisms from the single colony were cultured in an HPN minimal medium to validate the degradability of nitrogen thereof. The culture broth showing the growth of the microorganisms was plated onto a solid medium and cultured at 30°C , and the microorganisms were purely isolated.
- Example 1 To identify the microorganism isolated in Example 1 , an MIDI method, a cell wall fatty acid analysis method, was carried out, and for a more accurate analysis, the base sequencing of 16S rRNA was conducted. The results of the MIDI analysis showed that said microorganism had similarity index of 0.735 to Alcaligenes faecalis (FIG. 1).
- 16S rRNA was amplified using the purified chromosome as a template and primers of SEQ ID NOs: 2 and 3 (Wilson et al., Appl. Environ. Microbiol, 71 :290, 2005).
- SEQ ID NO: 2 forward primer AF16S rRNAF: 5-TTG GAT CCA GAG TTT GAT CMT GGC TCA G-3
- SEQ ID NO: 3 reverse primer AF16S rRNAR: 5-GTT GGA TCC ACG GYT ACC TTG TTA CGA YT-3
- Each sequence of 500 bases in the 16S rRNA base sequence (SEQ ID NO: 1) of said microorganism was determined. On the basis of the determined base sequence, it was found from the Clustal X program that said microorganism has a similarity more than 99% to the Alcaligenes faecalis KCTC 2678 strain.
- Example 1 the microorganism isolated in Example 1 was named "Alcaligenes faecalis LGNA2" and deposited with the Korean Collection for Type Cultures (KCTC), the Korea Research Institute of Bioscience and Biotechnology, on February 15, 2005 under accession No. KCTC 10779BP).
- KCTC Korean Collection for Type Cultures
- the regioselective hydroxylation of nitrogen-containing six-membered cyclic compounds was carried out using a novel microbial strain Alcaligenes faecalis LGNA2, and then the structures of the resulting products were determined in order to validate the hydroxylation of the compounds.
- a microbial strain was collected from the culture medium by centrifugation, washed with 50 mM Tris-HCl buffer (pH 7.0), and then suspended in 2.8 mL of the same buffer.
- 50 mM Tris-HCl buffer (pH 7.0) and nicotinic acid (final concentration: 20 g/L) were added, the mixture was allowed to react in a shaking incubator under conditions of 200 rpm and 30 °C , and then nicotinic acid and the product were detected by HPLC.
- a solvent for HPLC a mixed solution of methanol and water (29:60 v/v) was used.
- FIG. 2A and 2B show HPLC chromatograms of a product at 0 hour and 63 hours after performing the conversion of nicotinic acid using Alcaligenes faecalis LGNA2, respectively and
- FIG 2C shows HPLC chromatogram of standard 6- hydroxynicotinic acid. From the results in FIG. 2, it could be observed that 10.5 g/L of 6-hydroxynicotinic acid was produced at 63 hours after the reaction.
- FIG. 3 shows the 1 H-NMR spectrum of the product resulting from the conversion of nicotinic acid, caused by Alcaligenes faecalis LGNA2. More specifically, FIG. 3A shows the 1 H-NMR spectrum of standard 6-hydroxynicotinic acid, and FIG.
- FIG. 3B shows the 1 H-NMR spectrum of the product resulting from the conversion of nicotinic acid, caused by Alcaligenes faecalis LGNA2.
- FIG. 4 shows the mass spectrometry spectrum of the product resulting from the conversion of nicotinic acid, caused by Alcaligenes faecalis LGNA2. More specifically, FIG. 4A shows the MS spectrum of standard 6-hydroxynicotinic acid, and FIG. 4B shows the MS spectrum of the product by converting nicotinic acid using Alcaligenes faecalis LGNA2.
- Alcaligenes faecalis LGNA2 was seeded into 2 ml of YEPD (10g/L yeast extract, 20g/L Bacto peptone, 20g/L glucose), and cultured in a shaking incubator at 200 rpm and 30 ° C for 16 hours.
- YEPD yeast extract, 20g/L Bacto peptone, 20g/L glucose
- nicotinic acid final concentration of 5 g/L
- the cultured Alcaliganes faecalis LGNA 2 was cultured for 20 hours (50% of nicotinic acid was converted into 6-hydroxynicotinic acid at 20 hours).
- the culture medium was centrifuged to obtain a microbial fraction, which was then washed with 50 mM potassium phosphate buffer and suspended in 8 mL of the same buffer.
- 50 mM potassium phosphate buffer 50 mM potassium phosphate buffer and suspended in 8 mL of the same buffer.
- 2 mL of pyrazine carboxylic solution 6.21 g/L
- was added to a final concentration of 4.14 g/L followed by reaction.
- FIG. 5A, 5B and 5C are HPLC chromatograms of a product resulting from the conversion of pyrazime carboxylic acid using Alcaligenes paecalis LGNA2, which show HPLC results measured at 0 hour, 4 hours and 20 hours after the conversion reaction, respectively. From the results in FIG. 5, it could be observed that 100% of pyrazine carboxylic acid was converted within 20 hours after the reaction.
- Microbial cells were removed from the reaction solution by centrifugation, and the remaining solution was adjusted to pH 1.2 with 6N HCl. The formed precipitate was collected and washed with water (pH 1.2), followed by drying at 30 ° C (52% yield). The dried substance was dissolved in DMSO-d6 solvent and then subjected to 1 H NMR analysis and MS analysis (FIGs. 6 and 7).
- FIG. 6 shows the 1 H-NMR spectrum of the product resulting from the conversion of pyrazine carboxylic acid, caused by Alcaligenes faecalis LGNA2. More specifically, FIG. 6A shows the 1 H-NMR spectrum of reactant pyrazine carboxylic acid, and FIG. 6B shows the 1 H-NMR spectrum of the reaction product. Also, FIG. 7 illustrates the mass spectrometry (MS) spectra of the product resulting from the conversion of pyrazine carboxylic acid, caused by Alcaligenes faecalis LGNA2.
- MS mass spectrometry
- Peak 1 coincides with the molecular weight of hydroxypyrazine carboxylic acid
- peak 2 is the MS spectrum of a trace amount of a dimmer.
- the present invention provides the microorganism
- the microorganism according to the present invention catalyzes the direct conversion of said compounds, the use of the inventive microorganism leaves little or no byproducts after the final reaction, thus making it easy to isolate and purify the product, and also results in high conversion efficiency. Accordingly, the inventive microorganism can be widely used in synthesizing nicotine and pyrazine derivatives in large amounts.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pyridine Compounds (AREA)
Abstract
The present invention relates to a novel microorganism of the genus Alcaligenes, which catalyzes the regioselective hydroxylation of nitrogen-containing six-membered cyclic compounds, including nicotinic acid, pyrazine carboxylic acid and picolinic acid, as well as a method for producing a nitrogen-containing hydroxylated six-membered cyclic compound using said microorganism. The novel microorganism Alcaligenes faecalis LGNA2 according to the present invention is effective in catalyzing the regioselective hydroxylation of nitrogen-containing six-membered cyclic compounds such as nicotinic acid, pyrazine carboxylic acid and picolinic acid and has a high efficiency for converting the six-membered cyclic compounds into other compounds. Accordingly, it can be widely used in synthesizing nicotine and pyrazine derivatives in large amounts.
Description
Novel Microorganism Catalyzing Regioselective Hydroxylation of 6
Cyclic Compound Containing Nitrogen and Method for Producing
Hydroxylated 6 Cyclic Compound Containing Nitrogen Using the Same
TECHNICAL FIELD
The present invention relates to a novel microorganism of the genus Alcaligenes, which catalyzes the regioselective hydroxylation of nitrogen-containing six- memhered cyclic compounds, including nicotinic acid, pyrazine carboxylic acid and picolinic acid, as well as a method for producing a nitrogen-containing hydroxylated six-membered cyclic compound using said microorganism.
BACKGROUND ART
Imidacloprid and related compounds, which are used as insecticides, have a significant difference from existing insecticides such as organophorphorus compounds, carbamates and pyrethroids with respect to the structure and function thereof. Substances which are commonly present in nicotinoid compounds, including Imidacloprid, include 6-hydroxynicotinic acid. For the synthesis of 6- hydroxynicotinic acid, the Kolbe-Schmitt reaction is used, but has shortcomings in that it has a yield of only about 45% and requires a high-pressure (130 arm) carbon dioxide atmosphere and a high-temperature (250 °C) reaction condition. For this reason, there has been a need to develop a process of producing 6-hydroxynicotinic acid with a higher yield in a milder condition compared to the Kolbe-Schmitt reaction.
Processes of producing 6-hydroxynicotinic acid from nicotinic acid using a microbial biocatalyst have been reported, but these processes mainly employed a
method of accumulating 6-hydroxynicotinic acid in the metabolic process of nicotinic acid degradation products which are used as a nitrogen source and carbon source for microorganisms. For example, microorganisms accumulating 6- hydroxynicotinic acid, the first product of the nicotinic acid degradation process, were isolated mainly by an enrichment process. Examples of the isolated microorganisms include Achromobacter xylosoxidans LKl) (Kulla, H., Chimia, 45:81, 1991), Pseudomomas fluorescens TN5) (Nagasawa et ah, Biosci. Biotechnol. Biochem., 58:665, 1994) and Serratia marcescens IFO 12648) (Hurh et al, J. Ferment. Technol, 77:382, 1994).
Meanwhile, JP Publication No.1998-262691 discloses a microorganism of the genus Serratia, which can produce 3-hydroxynicotinic acid by catalyzing a hydroxylation reaction involving the decarboxylation of the carboxyl group of nicotinic acid. Also, JP Registration No. 3220210 discloses a microorganism of the genus Agrobacterium, which can convert 3-cyanopyridine into 6- hydroxynicotinic acid.
However, there is still no report on a microorganism which not only catalyzes the direct regioselective hydroxylation of nicotinic acid to produce 6-hydroxynicotinic acid, but also catalyzes the regioselective hydroxylation of other kinds of nitrogen- containing six-membered cyclic compounds such as pyrazine carboxylic acid and picolinic acid.
Thus, the present inventors have made extensive efforts to isolate a microorganism catalyzing the regioselective hydroxylation of nitrogen-containing six-membered cyclic compounds. As a result, the present inventors have isolated a novel microorganism Alcaligenes faecalis LGNA2 capable of effectively producing 6- hydroxynicotinic acid by examining the conversion of nicotinic acid in microorganisms isolated during the degradation process of nitrile compounds (e.g., 3-hydroxypropionitrile, 3-cyanopyridine, etc.), and found that this microorganism
can convert nicotinic acid into 6-hydroxynicotinic acid, thereby completing the present invention.
SUMMARY OF THE INVENTION
A main object of the present invention is to provide a novel microorganism which not only catalyzes the regioselective reaction of nicotinic acid to produce 6- hydroxylicotinic acid with high efficiency, but also catalyzes the regioselective hydroxylation of nitrogen-containing six-membered cyclic compounds.
Another object of the present invention is to provide a method for producing a nitrogen-containing hydroxylated six-membered cyclic compound using said microorganism.
To achieve the above objects, the present invention provides a microorganism of the genus Alcaligenes, which catalyzes the regioselective hydroxylation of a compound represented by Formula 1 : [Formula 1]
wherein R is a carbon atom or a nitrogen atom, and Rl and R2 are each independently hydrogen, a carboxyl group, a carbamoyl group, a cyano group, a formyl group, a C1-Cs hydroxyalkyl group, a C2-C6 alkoxycarbonyl group, a carboxylvinyl group, a carboxymethyl group or an oxime group, with the proviso that one of Rl and R2 must be a carboxyl group.
In another aspect, the present invention provides a method for producing a
compound represented by Formula 2, the method comprising carrying out the selective hydroxylation of a compound represented by Formula 1 using said microorganism of the genus Alcaligenes: [Formula 2]
wherein R is a carbon atom or a nitrogen atom, and Rl and R2 are each independently hydrogen, a carboxyl group, a carbamoyl group, a cyano group, a formyl group, a C1-C5 hydroxyalkyl group, a C2-C6 alkoxycarbonyl group, a carboxylvinyl group, a carboxymethyl group or an oxime group, with the proviso that one of Rl and R2 must be a carboxyl group.
In still another aspect, the present invention provides a method for preparing an enzyme catalyzing the regioselective hydroxylation of the compound represented by Formula 1, the method comprising culturing said microorganism of the genus Alcaligenes; and recovering the enzyme catalyzing the regioselective hydroxylation of the compound represented by Formula 1 from the cultured microorganism. Also, the present invention provides a method for producing the compound of Formula 2, the method comprising carrying out the selective hydroxylation of the compound of Formula 1 using the enzyme prepared by said method, or a crushed substance or fraction of the microorganism containing said enzyme.
In the present invention, said microorganism of the genus Alcaligenes is preferably Alcaligenes faecalis, and has 16S rRNA having a homology of more than 99% to a base sequence of SEQ ID NO: 1. More preferably, said microorganism of the genus Alcaligenes is Alcaligenes faecalis LGNA2 (KCTC 10779BP).
In the present invention, the compound represented by Formula 1 is preferably selected from the group consisting of nicotinic acid, pyrazine carboxylic acid and
picolinic acid.
The above and other objects, features and embodiments of the present invention will be more clearly understood from the following detailed description and accompanying claims.
BRIEF DESCRIPTION OF DRAWINGS
FIG. 1 shows identification results obtained by microbial fatty acid analysis (MIDI) of Alcaligenes faecalis LGNA2, a novel microorganism isolated according to the present invention.
FIG. 2A and 2B show HPLC chromatograms of a product at 0 hour and 63 hours after performing the conversion of nicotinic acid using Alcaligenes faecalis LGNA2, and FIG 2C shows HPLC chromatogram of standard 6-hydroxynicotinic acid.
FIG. 3 A shows the 1H-NMR spectrum of standard 6-hydroxynicotinic acid, and FIG. 3B shows the 1H-NMR spectrum of a product resulting from the conversion of nicotinic acid, caused by Alcaligenes faecalis LGNA2.
FIG. 4A shows the mass spectrometry (MS) spectrum of standard 6- hydroxynicotinic acid, and FIG. 4B shows the MS spectrum of a product resulting from the conversion of nicotinic acid, caused by Alcaligenes faecalis LGNA2.
FIG. 5A, 5B and 5C show an HPLC chromatogram of a product resulting from the conversion of pyrazine carboxylic acid, caused by Alcaligenes faecalis LGNA2 at 0 hour, 4 hours and 20 hours after the conversion reaction, respectively.
FIG. 6 shows 1H-NMR spectra illustrating the conversion of pyrazine carboxylic acid, caused by Alcaligenes faecalis LGNA2. FIG. 6A shows the 1H-NMR spectrum of reactant pyrazine carboxylic acid, and FIG. 6B shows the H-NMR spectrum of a reaction product.
FIG. 7 illustrates the mass spectrometry (MS) spectra of a product resulting from the conversion of pyrazine carboxylic acid, caused by Alcaligenes faecalis LGNA2, and shows an LC-MS spectrum, the MS spectrum of peak 1 and the MS spectrum of peak 2, starting with the top of the figure, respectively.
DETAILED DESCRIPTION OF THE INVENTION AND PREFERRED EMBODIMENTS
In the present invention, Alcaligenes faecalis LGNA2, a novel microorganism of the genus Alcaligenes, was obtained using a method of isolating the microorganism during the degradation process of nitrile compounds, instead of using a method of isolating a microorganism producing 6-hydroxynicotinic acid through the degradation of nicotinic acid, and it was found that the obtained microorganism converts nicotinic acid into 6-hydroxynicotinic acid with high efficiency.
The present invention, in one aspect, relates to a microorganism of the genus Alcaligenes which catalyzes the regioselective hydroxylation of a compound represented by Formula 1 and a method for producing a compound represented by Formula 2, the method comprising carrying out the selective hydroxylation of a compound represented by Formula 1 using said microorganism of the genus Alcaligenes:
[Formula 1]
[Formula 2]
wherein R is a carbon atom or a nitrogen atom, and Rl and R2 are each independently hydrogen, a carboxyl group, a carbamoyl group, a cyano group, a formyl group, a C1-Cs hydroxyalkyl group, a C2-C6 alkoxycarbonyl group, a carboxylvinyl group, a carboxymethyl group or an oxime group, with the proviso that one of Rl and R2 must be a carboxyl group.
In the case of using the microorganism of the genus Alcaligenes according to the present invention, a hydroxide represented by Formula 2 could be produced directly by catalyzing the regioselective hydroxylation of a nitrogen-containing 6- membered cyclic compound represented by Formula 1.
For example, the microorganism according to the present invention not only can catalyze the regioselective hydroxylation of nicotinic acid to produce 6- hydroxynicotinic acid, but also can convert 2-pyrazinecarboxylic acid and picolinic acid into 5-hydroxy pyrazine-2-carboxylic acid and 6-hydroxypicolinic acid, respectively.
Meanwhile, in the preparation of the hydroxide represented by Formula 2, instead of the microorganism of the genus Alcaligenes, an enzyme catalyzing the
regioselective hydroxylation of the compound represented by Formula 1 recovered from the microorganism of the genus Alcaligenes can be used.
The present invention, in another aspect, relates to a method for preparing an enzyme catalyzing the regioselective hydroxylation of the compound represented by Formula 1 , the method comprising culturing said microorganism of the genus
Alcaligenes; and recovering the enzyme catalyzing the regioselective hydroxylation of the compound represented by Formula 1 from the cultured microorganism, and a method for producing the compound of Formula 2, the method comprising carrying out the selective hydroxylation of the compound of Formula 1 using the enzyme prepared by said method or a crushed substance or fraction of the microorganism containing said enzyme.
The enzyme catalyzing the regioselective hydroxylation of the compound represented by Formula 1 can be retrieved from the cultured microorganism of the genus Alcaligenes using the conventional method. For example, a method for recovering the enzyme comprising the steps of: collecting the cells from the culture broth by centrifugation, etc; crushing the collected cells; and applying to chromatography, etc.
As used herein, the term "crushed substance" refers to a substance which is obtained by crushing cultured microorganism with, for example, a grinder, and contains the inventive enzyme capable of catalyzing the hydroxylation of nitrogen- containing six-membered cyclic compounds. Also, the term "fraction" refers to a substance which is obtained by partially purifying an enzyme from said crushed substance and contains the inventive enzyme capable of catalyzing the hydroxylation of nitrogen-containing six-membered cyclic compounds.
Examples
Hereinafter, the present invention will be described in more detail by specific examples. However, the present invention is not limited to these examples, and it is obvious to those skilled in the field of the present invention that numerous variations or modifications could be made within the spirit and scope of the present invention.
Example 1; Isolation of microorganism converting nicotinic acid into 6- hydroxynicotinic acid
First, a microorganism that degrades 3-hydroxypropionitrile and uses the degraded substance as a single carbon source was isolated from a soil source.
As liquid media for the isolation of the microorganism, GHPN medium and HPN medium were prepared and used. The GHPN medium was prepared by adding 5 g/L of glucose and 20 g/L of 3-hydroxypropionitrile as a nitrogen source to a minimal medium containing the components shown in Tables 1 and 2. Also, the HPN medium, a medium of using 3-hydroxypropionitrile as a single carbon source and nitrogen source, was prepared by adding 20 g/L of 3-hydroxypropionitrile as a nitrogen source to a minimal medium containing the components shown in Tables 1 and 2. In solid culture, solid media (HPN agar) prepared by adding glucose (10 g/L) as a carbon source and 3-hydroxypropionitrile as a nitrogen source (5 g/L) to LB medium plate and minimal media were used.
To screen microorganisms degrading nitrile, 1 g of a soil microbial source was added into 5 ml of liquid medium (GHPN medium and HPN medium) and subjected to enrichment culture in a shaking incubator under conditions of 200 rpm and 30°C for 3 days. Then, 1 ml of the culture broth as a microbial source was seeded again into the same liquid medium as described above, and then subjected to enrichment culture in the same conditions as described above. The culture process was repeated three times, and then the culture broth was plated onto an
HPN agar solid medium, and cultured to produce a single colony. Microorganisms from the single colony were cultured in an HPN minimal medium to validate the degradability of nitrogen thereof. The culture broth showing the growth of the microorganisms was plated onto a solid medium and cultured at 30°C , and the microorganisms were purely isolated.
Table 1 : Components of minimal medium
Table 2: Components of metal solution and vitamin solution
Example 2; Identification of isolated LGN A2 microorganism
To identify the microorganism isolated in Example 1 , an MIDI method, a cell wall fatty acid analysis method, was carried out, and for a more accurate analysis, the base sequencing of 16S rRNA was conducted. The results of the MIDI analysis showed that said microorganism had similarity index of 0.735 to Alcaligenes
faecalis (FIG. 1).
To determine the base sequence of 16S rRNA, the chromosome of each of said microorganism and an Alcaligenes faecalis KCTC 2678 strain known as the standard bacterial strain of Alcaligenes faecalis was isolated and purified using reagents for isolating and purifying chromosomes. Then, 16S rRNA was amplified using the purified chromosome as a template and primers of SEQ ID NOs: 2 and 3 (Wilson et al., Appl. Environ. Microbiol, 71 :290, 2005).
SEQ ID NO: 2 (forward primer AF16S rRNAF): 5-TTG GAT CCA GAG TTT GAT CMT GGC TCA G-3
SEQ ID NO: 3 (reverse primer AF16S rRNAR): 5-GTT GGA TCC ACG GYT ACC TTG TTA CGA YT-3
Each sequence of 500 bases in the 16S rRNA base sequence (SEQ ID NO: 1) of said microorganism was determined. On the basis of the determined base sequence, it was found from the Clustal X program that said microorganism has a similarity more than 99% to the Alcaligenes faecalis KCTC 2678 strain.
On the basis of said analysis results, the microorganism isolated in Example 1 was named "Alcaligenes faecalis LGNA2" and deposited with the Korean Collection for Type Cultures (KCTC), the Korea Research Institute of Bioscience and Biotechnology, on February 15, 2005 under accession No. KCTC 10779BP).
Example 3: Regioselective hydroxylation of nitrogen-containing six-membered cyclic compounds
The regioselective hydroxylation of nitrogen-containing six-membered cyclic compounds, including nicotinic acid and pyrazine carboxylic acid, was carried out using a novel microbial strain Alcaligenes faecalis LGNA2, and then the structures of the resulting products were determined in order to validate the hydroxylation of
the compounds.
3-1. Hydroxylation of nicotinic acid
Alcaligenes faecalis LGNA2 was cultured in 3 mL of YEPD (10 g/L yeast extract, 20 g/L Bacto peptone, and 20 g/L glucose) for 16 hours. To induce an enzyme catalyzing hydroxylation, nicotinic acid was then added to 50 mL of the same YEPD medium to a final concentration of 20 g/L, and the medium was incubated for 39 hours (OD600= 1.73).
A microbial strain was collected from the culture medium by centrifugation, washed with 50 mM Tris-HCl buffer (pH 7.0), and then suspended in 2.8 mL of the same buffer. To 0.5 mL of the microbial suspension, 3.5 mL of 50 mM Tris-HCl buffer (pH 7.0) and nicotinic acid (final concentration: 20 g/L) were added, the mixture was allowed to react in a shaking incubator under conditions of 200 rpm and 30 °C , and then nicotinic acid and the product were detected by HPLC. As a solvent for HPLC, a mixed solution of methanol and water (29:60 v/v) was used. The flow rate of the solvent in a Capcellpak Cl 8 column was maintained at 1 ml/min, and HPLC detection was performed at UV 230 nm (FIG. 2). FIG. 2A and 2B show HPLC chromatograms of a product at 0 hour and 63 hours after performing the conversion of nicotinic acid using Alcaligenes faecalis LGNA2, respectively and FIG 2C shows HPLC chromatogram of standard 6- hydroxynicotinic acid. From the results in FIG. 2, it could be observed that 10.5 g/L of 6-hydroxynicotinic acid was produced at 63 hours after the reaction.
After 5 days of the reaction, the reaction solution was centrifuged to remove microbial cells, and adjusted to pH 1.8 with 6N HCl. Then, the precipitate was collected, washed with water (pH 1.8), followed by drying at 30 °C (52% yield). The dried precipitate was dissolved in DMSO-d6 solvent and then subjected to 1H NMR and MS analysis (FIGs. 3 and 4).
FIG. 3 shows the 1H-NMR spectrum of the product resulting from the conversion of nicotinic acid, caused by Alcaligenes faecalis LGNA2. More specifically, FIG. 3A shows the 1H-NMR spectrum of standard 6-hydroxynicotinic acid, and FIG. 3B shows the 1H-NMR spectrum of the product resulting from the conversion of nicotinic acid, caused by Alcaligenes faecalis LGNA2. Also, FIG. 4 shows the mass spectrometry spectrum of the product resulting from the conversion of nicotinic acid, caused by Alcaligenes faecalis LGNA2. More specifically, FIG. 4A shows the MS spectrum of standard 6-hydroxynicotinic acid, and FIG. 4B shows the MS spectrum of the product by converting nicotinic acid using Alcaligenes faecalis LGNA2.
As shown in FIGs. 3 and 4, it could be observed that the 1H-NMR spectrum and the MS spectrum of the reaction product coincided with those of the standard 6- hydroxynicotinic acid.
3-2. Hydroxylation of pyrazine carboxylic acid
Alcaligenes faecalis LGNA2 was seeded into 2 ml of YEPD (10g/L yeast extract, 20g/L Bacto peptone, 20g/L glucose), and cultured in a shaking incubator at 200 rpm and 30°C for 16 hours. To the 100 mL of the same culture medium, nicotinic acid (final concentration of 5 g/L) was added, and then the cultured Alcaliganes faecalis LGNA 2 was cultured for 20 hours (50% of nicotinic acid was converted into 6-hydroxynicotinic acid at 20 hours). The culture medium was centrifuged to obtain a microbial fraction, which was then washed with 50 mM potassium phosphate buffer and suspended in 8 mL of the same buffer. To 1 mL of the microbial suspension, 2 mL of pyrazine carboxylic solution (6.21 g/L), was added to a final concentration of 4.14 g/L, followed by reaction.
To analyze the reaction solution, a mixed solution of acetonitrile and water (4:96
v/v; adjusted to pH 2.5 with H3PO4) was used as an HPLC solvent, the flow rate of the solvent in a Capcellpak Cl 8 column was maintained at 1 ml/min, and HPLC detection was performed at UV 230 nm. FIG. 5A, 5B and 5C are HPLC chromatograms of a product resulting from the conversion of pyrazime carboxylic acid using Alcaligenes paecalis LGNA2, which show HPLC results measured at 0 hour, 4 hours and 20 hours after the conversion reaction, respectively. From the results in FIG. 5, it could be observed that 100% of pyrazine carboxylic acid was converted within 20 hours after the reaction.
Microbial cells were removed from the reaction solution by centrifugation, and the remaining solution was adjusted to pH 1.2 with 6N HCl. The formed precipitate was collected and washed with water (pH 1.2), followed by drying at 30 °C (52% yield). The dried substance was dissolved in DMSO-d6 solvent and then subjected to 1H NMR analysis and MS analysis (FIGs. 6 and 7).
FIG. 6 shows the 1H-NMR spectrum of the product resulting from the conversion of pyrazine carboxylic acid, caused by Alcaligenes faecalis LGNA2. More specifically, FIG. 6A shows the 1H-NMR spectrum of reactant pyrazine carboxylic acid, and FIG. 6B shows the 1H-NMR spectrum of the reaction product. Also, FIG. 7 illustrates the mass spectrometry (MS) spectra of the product resulting from the conversion of pyrazine carboxylic acid, caused by Alcaligenes faecalis LGNA2. More specifically, and shows an LC-MS spectrum, the MS spectrum of peak 1 (hydroxypyrazine carboxylic acid) and the MS spectrum of peak 2 (hydroxypyrazine carboxylic acid dimmer), starting with the top of the figure, respectively. Peak 1 coincides with the molecular weight of hydroxypyrazine carboxylic acid, and peak 2 is the MS spectrum of a trace amount of a dimmer.
As shown in FIGs. 6 and 7, it could be observed that the reaction product was 5- hydroxypyrazine-2-carboxylic acid (mass analysis: 139=[M-H]-, 253=[M+CF3COO-]). However, a trace amount of a dimmer was produced as a
byproduct.
INDUSTRIAL APPLICABILITY
As described in detail above, the present invention provides the microorganism
(Alcaligenes faecalis LGNA2) effective in catalyzing the regioselective hydroxylation of nitrogen-containing six-membered cyclic compounds such as nicotinic acid, pyrazine carboxylic acid and picolinic acid, as well as the method for producing a nitrogen-containing hydroxylated six-membered cyclic compound using said microorganism. Because the microorganism according to the present invention catalyzes the direct conversion of said compounds, the use of the inventive microorganism leaves little or no byproducts after the final reaction, thus making it easy to isolate and purify the product, and also results in high conversion efficiency. Accordingly, the inventive microorganism can be widely used in synthesizing nicotine and pyrazine derivatives in large amounts.
Although a specific embodiment of the present invention has been described in detail, those skilled in the art will appreciate that this description is merely a preferred embodiment and is not construed to limit the scope of the present invention. Thus, the substantial scope of the present invention will be defined by the appended claims and equivalents thereof.
Claims
THE CLAIMS
What is claimed is:
L A microorganism of the genus Alcaligenes, which catalyzes the regioselective hydroxylation of a compound represented by Formula 1 below: [Formula 1]
wherein R is a carbon atom or a nitrogen atom, and Rl and R2 are each independently hydrogen, a carboxyl group, a carbamoyl group, a cyano group, a formyl group, a C1-C5 hydroxyalkyl group, a C2-C6 alkoxycarbonyl group, a carboxylvinyl group, a carboxymethyl group or an oxime group, with the proviso that one of Rl and R2 must be a carboxyl group.
2. The microorganism according to claim 1, wherein said microorganism of the genus Alcaligenes is Alcaligenes faecalis.
3. The microorganism according to claim 1, wherein said microorganism of the genus Alcaligenes has 16S rRNA having a homology of more than 99% to a base sequence of SEQ ID NO: 1.
4. The microorganism according to claim 1, wherein said microorganism of the genus Alcaligenes is Alcaligenes faecalis LGNA2 (KCTC 10779BP).
5. A method for producing a compound represented by Formula 2, the method comprising carrying out the selective hydroxylation of a compound represented by Formula 1 using the microorganism of the genus Alcaligenes:
[Formula 1]
[Formula 2]
wherein R is a carbon atom or a nitrogen atom, and Rl and R2 are each independently hydrogen, a carboxyl group, a carbamoyl group, a cyano group, a formyl group, a C1-C5 hydroxyalkyl group, a C2-C6 alkoxycarbonyl group, a carboxylvinyl group, a carboxymethyl group or an oxime group, with the proviso that one of Rl and R2 must be a carboxyl group.
6. The method according to claim 5, wherein said microorganism of the genus Alcaligenes is Alcaligenes faecalis.
7. The method according to claim 5, wherein said microorganism of the genus Alcaligenes has 16S rRNA having a homology of more than 99% to a base sequence of SEQ ID NO: 1.
8. The method according to claim 5, wherein said microorganism of the genus Alcaligenes is Alcaligenes faecalis LGNA2 (KCTC 10779BP).
9. The method according to claim 5, wherein the compound represented by Formula 1 is selected from the group consisting of nicotinic acid, pyrazine carboxylic acid and picolinic acid.
10. A method for preparing an enzyme catalyzing the regioselective hydroxylation
of the compound represented by Formula 1 , the method comprising culturing the microorganism of any one claim among claims 1-4; and recovering the enzyme catalyzing the regioselective hydroxylation of the compound represented by Formula 1 from the cultured microorganism: [Formula 1]
wherein R is a carbon atom or a nitrogen atom, and Rl and R2 are each independently hydrogen, a carboxyl group, a carbamoyl group, a cyano group, a formyl group, a C1-C5 hydroxyalkyl group, a C2-C6 alkoxycarbonyl group, a carboxylvinyl group, a carboxymethyl group or an oxime group, with the proviso that one of Rl and R2 must be a carboxyl group.
11. A method for producing the compound represented by Formula 2, the method comprising carrying out the selective hydroxylation of the compound represented by Formula 1 using the enzyme prepared by the method of claim 10, or a crushed substance or fraction of the microorganism containing said enzyme: [Formula 1]
[Formula 2]
wherein R is a carbon atom or a nitrogen atom, and Rl and R2 are each independently hydrogen, a carboxyl group, a carbamoyl group, a cyano group, a
formyl group, a C1-C5 hydroxyalkyl group, a C2-C6 alkoxycarbonyl group, a carboxylvinyl group, a carboxymethyl group or an oxime group, with the proviso that one of Rl and R2 must be a carboxyl group.
12. The method according to claim 11, wherein the compound represented by Formula 1 is selected from the group consisting of nicotinic acid, pyrazine carboxylic acid and picolinic acid.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020050065198A KR20070010527A (en) | 2005-07-19 | 2005-07-19 | Novel microorganism catalyzing regioselective hydroxylation of 6 cyclic compound containing nitrogen and method for producing hydroxylated 6 cyclic compound containing nitrogen using the same |
KR10-2005-0065198 | 2005-07-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2007011156A1 true WO2007011156A1 (en) | 2007-01-25 |
Family
ID=37669007
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2006/002823 WO2007011156A1 (en) | 2005-07-19 | 2006-07-19 | Novel microorganism catalyzing regioselective hydroxylation of 6 cyclic compound containing nitrogen and method for producing hydroxylated 6 cyclic compound containing nitrogen using the same |
Country Status (2)
Country | Link |
---|---|
KR (1) | KR20070010527A (en) |
WO (1) | WO2007011156A1 (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5082777A (en) * | 1984-02-21 | 1992-01-21 | Lonza Ltd. | Process for the production of 6-hydroxynicotinic acid |
US5182197A (en) * | 1991-02-04 | 1993-01-26 | Lonza Ltd. | Microbiological process for the production of 6-hydroxypicolinic acid |
US5273893A (en) * | 1991-06-21 | 1993-12-28 | Lonza Ltd. | Microbiological process for the production of hydroxypyrazinecarboxylic acid |
US5516661A (en) * | 1991-12-05 | 1996-05-14 | Lonza Ltd. | Microbiological process for the production of aromatic hydroxy-heterocyclic carboxylic acids |
-
2005
- 2005-07-19 KR KR1020050065198A patent/KR20070010527A/en not_active Application Discontinuation
-
2006
- 2006-07-19 WO PCT/KR2006/002823 patent/WO2007011156A1/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5082777A (en) * | 1984-02-21 | 1992-01-21 | Lonza Ltd. | Process for the production of 6-hydroxynicotinic acid |
US5182197A (en) * | 1991-02-04 | 1993-01-26 | Lonza Ltd. | Microbiological process for the production of 6-hydroxypicolinic acid |
US5273893A (en) * | 1991-06-21 | 1993-12-28 | Lonza Ltd. | Microbiological process for the production of hydroxypyrazinecarboxylic acid |
US5516661A (en) * | 1991-12-05 | 1996-05-14 | Lonza Ltd. | Microbiological process for the production of aromatic hydroxy-heterocyclic carboxylic acids |
Also Published As
Publication number | Publication date |
---|---|
KR20070010527A (en) | 2007-01-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9822335B2 (en) | Amycolatopsis sp. strain and methods of using the same for vanillin production | |
EP0449648B1 (en) | Process for producing R(-)-mandelic acid and derivatives thereof | |
CN112795603B (en) | Method for preparing (S) -2- (3-pyridine) -pyrrolidine | |
WO1997000968A1 (en) | Reduction of ketone groups | |
Xiao et al. | Tetramethylpyrazine production from glucose by a newly isolated Bacillus mutant | |
JPH0499497A (en) | Production of optically active lactic acid | |
JPH04365494A (en) | Microbiological method for producing hydroxylated pyrazine derivative | |
CN110982757B (en) | Enterobacter cloacae ZJPH1903 and application | |
JP3703928B2 (en) | Process for producing optically active N-benzyl-3-pyrrolidinol | |
WO2007011156A1 (en) | Novel microorganism catalyzing regioselective hydroxylation of 6 cyclic compound containing nitrogen and method for producing hydroxylated 6 cyclic compound containing nitrogen using the same | |
CN107794282B (en) | Preparation method and strain of crizotinib chiral intermediate | |
EP0982406A2 (en) | Microbial production of actinol | |
US6379935B1 (en) | Method of producing α-halo-α,β-saturated carbonyl compounds from the corresponding α,β-unsaturated compounds | |
WO2013133497A1 (en) | Method and composition for high-yield preparation of gamma-dodecalactone from hydroxy fatty acids | |
JP4395005B2 (en) | Strain producing low degree of polymerization ε-poly-L-lysine and method for producing low degree of polymerization ε-poly-L-lysine using the same | |
WO1992012251A1 (en) | Process for producing (r)-malic acid, microbial maleate hydratase, and process for producing said hydratase | |
US5496715A (en) | Process for preparing indigo | |
EP2551351A1 (en) | Process for production of optically active (R)-(-)-1-(2,4-dichloro-phenyl)-2-imidazole-1-yl-ethanol | |
EP0862645A1 (en) | Stereoselective microbial reduction process | |
JP3843692B2 (en) | Process for the production of optically active endo-norborneol | |
JP3010850B2 (en) | Process for producing (S)-(+)-3-halo-1,2-propanediol and / or (S)-(-)-2,3-dihalo-1-propanol | |
EP0979877B1 (en) | Method of producing alpha-halo-alpha, beta-saturated carbonyl compounds | |
US5716815A (en) | Method for preparing dimethylcarboxylic acid compounds | |
JP5126707B2 (en) | Method for producing α-hydroxyacylpyridine | |
JP3754785B2 (en) | Method for producing 3-hydroxy nitrogen-containing six-membered ring compound |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 06783341 Country of ref document: EP Kind code of ref document: A1 |